Latest Articles
Humacyte to raise $50M; Acrivon to focus on prexasertib in endometrial cancer - Endpoints News
Humacyte to raise $50M; Acrivon to focus on prexasertib in endometrial cancer Endpoints News
Published: March 26, 2025, 2:10 p.m.
Acrivon stops developing Lilly castoff for ovarian and bladder cancers to switch focus to endometrial - Fierce Biotech
Acrivon stops developing Lilly castoff for ovarian and bladder cancers to switch focus to endometrial Fierce Biotech
Published: March 26, 2025, 11:05 a.m.
Promising Phase 2 Results for ACR-368 in Endometrial Cancer Justify Buy Rating - TipRanks
Promising Phase 2 Results for ACR-368 in Endometrial Cancer Justify Buy Rating TipRanks
Published: March 26, 2025, 10:20 a.m.
Endometrial Organoids Are Advancing Women’s Health - Technology Networks
Endometrial Organoids Are Advancing Women’s Health Technology Networks
Published: March 25, 2025, 5:01 p.m.
Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit - AboutLawsuits.com
Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit AboutLawsuits.com
Published: March 25, 2025, 4 p.m.
Tampon-Based Test Detects Endometrial Cancer Using Vaginal Fluid Biomarkers - Medscape
Tampon-Based Test Detects Endometrial Cancer Using Vaginal Fluid Biomarkers Medscape
Published: March 25, 2025, 5:52 a.m.
Tampon Test Detects Endometrial Cancer - Medscape
Tampon Test Detects Endometrial Cancer Medscape
Published: March 25, 2025, 5:52 a.m.
University of Cincinnati Cancer Center Reports Metformin Enhances Treatment in ER-Positive Endometrial Cancer - Hoodline
University of Cincinnati Cancer Center Reports Metformin Enhances Treatment in ER-Positive Endometrial Cancer Hoodline
Published: March 24, 2025, 7:46 p.m.
Add-on metformin promising in ER-positive endometrial cancer - University of Cincinnati
Add-on metformin promising in ER-positive endometrial cancer University of Cincinnati
Published: March 24, 2025, 5:05 p.m.
The association of molecular classification with fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma：A retrospective study - Frontiers
The association of molecular classification with fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma：A retrospective study Frontiers
Published: March 24, 2025, 4:03 p.m.
Link copied to clipboard!